MRVI: Maravai LifeSciences Holdings Inc - Class A

MRVI新闻

• 08:58 Maravai LifeSciences 2026年第二季度财报电话会议全文记录
• 08:58 Full Transcript: Maravai LifeSciences Q2 2026 Earnings Call
• 20:02 中国国家知识产权局授予 Maravai LifeSciences 旗下 TriLink BioTechnologies 专利号 ZL202511246658.5，名称为“用于合成 5' 端加帽 RNA 的组合物和方法”。
• 20:02 China National Intellectual Property Administration Awards Maravai LifeSciences's TriLink BioTechnologies Patent Number ZL202511246658.5., Named "Compositions and Methods for Synthesizing 5'-Capped RNAs."
• 10:34 Perrigo (PRGO) Moves 6.1% Higher: Will This Strength Last?
• 14:25 Maravai LifeSciences: The Post-COVID Reset Has Created An RNA Consumables Flywheel (MRVI)
• 10:24 Maravai LifeSciences Holdings, Inc. (MRVI) Q2 2026 Earnings Call Transcript
• 03:32 Maravai LifeSciences Holdings, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-08-06
• 21:40 Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q2 Loss, Beats Revenue Estimates
• 18:20 The Disinflation Trade Has A New Address: Genomics
• 14:19 Maravai LifeSciences: Better Earnings Drive Gains That Ought To Be Sustainable (MRVI)
• 15:57 Maravai LifeSciences Holdings, Inc. (MRVI) Q1 2026 Earnings Call Transcript
• 21:55 Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q1 Earnings and Revenue Estimates
• 16:00 All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy
• 12:30 Baxter International (BAX) Tops Q1 Earnings and Revenue Estimates
• 05:31 Maravai LifeSciences Holdings, Inc. 2025 Q4 - Results - Earnings Call Presentation (NASDAQ:MRVI) 2026-02-26
• 00:25 Maravai LifeSciences Holdings, Inc. (MRVI) Reports Q4 Loss, Beats Revenue Estimates
• 23:31 Maravai 2025年第四季度业绩:削减成本后EBITDA转正
• 23:29 Maravai Q4 2025 slides: return to positive EBITDA on cost cuts
• 21:18 Maravai Lifesciences earnings beat by $0.03, revenue topped estimates
• 11:08 Maravai LifeSciences在3月公允价值警报后实现60%回报